Equities researchers at Royal Bank Of Canada initiated coverage on shares of Agilent Technologies (NYSE:A – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set an “outperform” rating and a $153.00 price target on the medical research company’s stock. Royal Bank Of Canada’s target price suggests a potential upside of 32.70% from the stock’s previous close.
Other equities analysts have also recently issued reports about the stock. Barclays lowered their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. TD Cowen decreased their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. UBS Group lowered their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Finally, Morgan Stanley dropped their price target on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Two research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $162.40.
Get Our Latest Research Report on A
Agilent Technologies Stock Performance
Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. During the same period in the previous year, the firm posted $1.31 EPS. The firm’s revenue was up 7.0% compared to the same quarter last year. On average, analysts anticipate that Agilent Technologies will post 5.95 EPS for the current fiscal year.
Hedge Funds Weigh In On Agilent Technologies
A number of hedge funds have recently bought and sold shares of A. Core Wealth Advisors LLC bought a new stake in Agilent Technologies during the fourth quarter valued at $26,000. SHP Wealth Management bought a new position in shares of Agilent Technologies in the 4th quarter worth about $26,000. Board of the Pension Protection Fund bought a new position in shares of Agilent Technologies in the 4th quarter worth about $27,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at about $27,000. Finally, Cedar Mountain Advisors LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $27,000. Institutional investors own 87.41% of the company’s stock.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Articles
- Five stocks we like better than Agilent Technologies
- Modine’s $4B AI Coup Freezes Out the Competition
- What Investors Need to Know About TSMC’s Hefty 17% Dividend Increase
- The SpaceX IPO Frenzy Is Creating 2 Very Different Bets
- AI Can’t Reach the Real World Without These 3 Stocks
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
